EFFECTS OF KETANSERIN, A SELECTIVE 5-HT2 SEROTONERGIC ANTAGONIST, ON THE SECONDARY RECRUITMENT OF HUMAN-PLATELETS INVITRO

被引:0
|
作者
DECLERCK, F
XHONNEUX, B
机构
来源
AGENTS AND ACTIONS | 1986年 / 17卷 / 5-6期
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:515 / 526
页数:12
相关论文
共 50 条
  • [21] EFFECT OF THE SELECTIVE 5-HT2 ANTAGONIST KETANSERIN ON ADENOSINE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTS
    CAZZOLA, M
    MATERA, MG
    SANTANGELO, G
    ASSOGNA, G
    DAMATO, G
    ROSSI, F
    GIRBINO, G
    IMMUNOPHARMACOLOGY, 1992, 23 (01): : 21 - 28
  • [22] VASCULAR ACTIVITY OF KETANSERIN (R41 468), A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST
    VANNUETEN, JM
    XHONNEUX, R
    VANHOUTTE, PM
    JANSSEN, PAJ
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1981, 250 (02): : 328 - 329
  • [23] TREATMENT OF RAYNAUDS-PHENOMENON WITH KETANSERIN, A SELECTIVE ANTAGONIST OF THE SEROTONIN2 (5-HT2) RECEPTOR
    SEIBOLD, JR
    JAGENEAU, AHM
    ARTHRITIS AND RHEUMATISM, 1984, 27 (02): : 139 - 146
  • [24] Ketanserin, a 5-HT2 receptor antagonist, reduces sleep apneas in rats
    Radulovacki, MN
    Pavlovic, S
    Rakic, A
    Janelidze, M
    Carley, DW
    SLEEP, 2001, 24 : A279 - A279
  • [25] Effects of a 5-HT2 receptor agonist (DOI) and a 5-HT2A receptor antagonist (ketanserin) on interval timing behaviour
    Body, S
    Kheramin, S
    Ho, MY
    Miranda, F
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A69 - A69
  • [26] DIVERGENT EFFECTS OF KETANSERIN, A 5-HT2 ANTAGONIST, ON THE PRESSOR AND TACHYCARDIAC RESPONSES TO 5-HYDROXYTRYPTAMINE IN RATS
    KRSTIC, MK
    KATUSIC, ZS
    IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1989, 25 : 73 - 74
  • [28] Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans
    Matthias E Liechti
    Matthias R Saur
    Alex Gamma
    Daniel Hell
    Franz X Vollenweider
    Neuropsychopharmacology, 2000, 23 : 396 - 404
  • [29] Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
    Liechti, ME
    Saur, MR
    Gamma, A
    Hell, D
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) : 396 - 404
  • [30] Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
    Levin, Edward D.
    Slade, Susan
    Johnson, Michael
    Petro, Ann
    Horton, Kofi
    Williams, Paul
    Rezvani, Amir H.
    Rose, Jed E.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) : 93 - 97